264 related articles for article (PubMed ID: 32002590)
1. A survey of TIR domain sequence and structure divergence.
Toshchakov VY; Neuwald AF
Immunogenetics; 2020 Apr; 72(3):181-203. PubMed ID: 32002590
[TBL] [Abstract][Full Text] [Related]
2. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
[TBL] [Abstract][Full Text] [Related]
3. Structural Evolution of TIR-Domain Signalosomes.
Nimma S; Gu W; Maruta N; Li Y; Pan M; Saikot FK; Lim BYJ; McGuinness HY; Zaoti ZF; Li S; Desa S; Manik MK; Nanson JD; Kobe B
Front Immunol; 2021; 12():784484. PubMed ID: 34868065
[TBL] [Abstract][Full Text] [Related]
4. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
[TBL] [Abstract][Full Text] [Related]
5. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
Li C; Zienkiewicz J; Hawiger J
J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
[TBL] [Abstract][Full Text] [Related]
7. Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling.
Fekonja O; Benčina M; Jerala R
J Biol Chem; 2012 Sep; 287(37):30993-1002. PubMed ID: 22829600
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide search of Toll/Interleukin-1 receptor (TIR) domain-containing adapter molecule (TICAM) and their evolutionary divergence from other TIR domain containing proteins.
Verma S; Sowdhamini R
Biol Direct; 2022 Sep; 17(1):24. PubMed ID: 36056415
[TBL] [Abstract][Full Text] [Related]
9. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.
Watters TM; Kenny EF; O'Neill LA
Immunol Cell Biol; 2007; 85(6):411-9. PubMed ID: 17667936
[TBL] [Abstract][Full Text] [Related]
11. Comparative and phylogenetic analyses of three TIR domain-containing adaptors in metazoans: implications for evolution of TLR signaling pathways.
Wu B; Xin B; Jin M; Wei T; Bai Z
Dev Comp Immunol; 2011 Jul; 35(7):764-73. PubMed ID: 21362440
[TBL] [Abstract][Full Text] [Related]
12. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
Carlsson E; Ding JL; Byrne B
Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the Toll/interleukin-1 receptor (TIR) domain of IL-1R10 provides structural insights into TIR domain signalling.
Nimma S; Gu W; Manik MK; Ve T; Nanson JD; Kobe B
FEBS Lett; 2022 Apr; 596(7):886-897. PubMed ID: 35038778
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling.
Ohnishi H; Tochio H; Kato Z; Orii KE; Li A; Kimura T; Hiroaki H; Kondo N; Shirakawa M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10260-5. PubMed ID: 19506249
[TBL] [Abstract][Full Text] [Related]
15. Diversity and evolution of TIR-domain-containing proteins in bivalves and Metazoa: New insights from comparative genomics.
Gerdol M; Venier P; Edomi P; Pallavicini A
Dev Comp Immunol; 2017 May; 70():145-164. PubMed ID: 28109746
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of Toll/interleukin-1 receptor/resistance protein (TIR) domains.
Ve T; Williams SJ; Kobe B
Apoptosis; 2015 Feb; 20(2):250-61. PubMed ID: 25451009
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Toll-interleukin 1 receptor mediated signaling.
Li X; Qin J
J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
[TBL] [Abstract][Full Text] [Related]
19. TIR-containing adaptors in Toll-like receptor signalling.
Jenkins KA; Mansell A
Cytokine; 2010 Mar; 49(3):237-44. PubMed ID: 19264502
[TBL] [Abstract][Full Text] [Related]
20. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
